Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Company News

Axxam and Sanofi to optimize CNS compounds

October 20, 2017 6:09 PM UTC

Axxam S.p.A. (Milan, Italy) said last month it partnered with Sanofi (Euronext:SAN; NYSE:SNY) to optimize lead small molecules, discovered by Axxam, in development to treat CNS diseases. Research will be performed at Sanofi and Axxam facilities. The pharma has an option to the programs...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article

BCIQ Company Profiles

Axxam S.p.A.

Sanofi